BCT
TSX:BCT
BriaCell Therapeutics Corp.
- Stock
locale
Canadamarket
STOCKSindustry
Biotechnologywebsite
www.briacell.comipo date
Aug 13, 2012
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-sh...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus